Morningstar | Essity’s Profitability Remains Hampered by Cost Pressures in 4Q, Despite Solid Top-Line Growth
No-moat Essity ended its fiscal year on largely solid footing, as strengthened pricing drove solid sales growth in the fourth quarter (up 3.3%, with more than three fourths of these gains driven by price/mix), while ongoing raw material cost pressures weighed on adjusted EBITA margin, which contracted 150 basis points to 11.1%. On a full-year basis, 8.5% top-line growth outpaced our expectations by around 100 basis points, but adjusted EBITA margins of 10.9% (140 basis points below the prior-year period) fell 70 basis points short of our estimate. These effects largely offset one another, with full-year earnings per share amounting to SEK 11.23, comparable to our SEK 11.26 estimate. As a result, we’re not anticipating a significant revision to our SEK 222 fair value estimate, outside of adjustments for the time value of money, and are reiterating our longer-term outlook, which calls for slightly below 4% organic sales growth and low-teens adjusted EBITA margin on average over the next five years. With shares up by a high-single-digit percentage on the announcement, we’d suggest investors wait for a more attractive entry point. Raw material cost headwinds had the most pronounced effect on the consumer tissue segment (38% of sales), with the market price for pulp increasing around 20% in the fourth quarter. However, we were pleased to see the firm’s efforts to improve pricing by reducing sales of its lower-margin offerings (with price/mix up 5.1%, versus a 0.5% decline in volume) help stabilize margin erosion in this segment. As evidence, adjusted EBITA margin of 6.9% (falling 130 basis points) marked a sequential improvement from the 5.8% posted in the third quarter (which had represented a contraction of 440 basis points). Although we maintain that a lack of differentiation in the commodified tissue business will constrain pricing power over the long run, we think positive mix effects and cost-saving initiatives will help Essity restore its margins over time.
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.
Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.
We have operations in 27 countries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.